——
Genetics Policy Institute (GPI)
-11924 Forest Hill Boulevard, Suite 22; Wellington, Florida 33414-6258 (888) 238.1423 | Fax: 561.791.3889 | Contact Us | http://www.genpol.org/about.html
——
—
Bernard F. Siegel - Founder; Executive Director; spokesman, etc.
American Jewish Joint Distribution Committee (JDC) « Fed up USA | http://www.iheu.org/node/2179 - He is an internationally known legal activist working to promote supportive legislation for stem cell research throughout the U.S. and the world. He is an authority on regulations pertaining to cloning technologies and has built an international constituency of scientists, “bioethicists”, legal scholars and patient-advocates for the promotion of stem cell research, etc.” …is a past co-chair of the ISSCR Government Affairs Committee, etc. | http://www.terrapinn.com/2008/stemcells/speakerList.stm http://www.iheu.org/node/2179 | Spouse[?]: Sheryl J Siegel. Wellington, Florida. | -bernard@genpol.org
******
Alan Fernandez – Director of Public Outreach & Development
http://www.linkedin.com/pub/alan-fernandez/19/61/b9b - San Francisco Bay Area. | -alan@genpol.org
******
Jerome “Jerry” E. Frenz – Chief Financial Officer
http://www.linkedin.com/pub/jerry-frenz/18/306/308 - CFO/COO at Prime Time Palm Beach County Inc. West Palm Beach [Wellington], Florida Area. | Jerry Frenz – Executive Profile - “Jerry E Frenz is associated with Adms Corporation with the role of Director. and is located in Wellington, FL.” | -Jerry@genpol.org******
——
—
Timothy Choate
* http://www.investorscopes.com/CHOATE-TIMOTHY-C/5/6477329.aspx -APTIMUS, Inc. | Sytronics, Inc.; American Access Technologies, Inc.; Digital River, Inc.; The Consus Group; etc. | Alexandria, Virginia.
* http://www.investorscopes.com/CHOATE-TIMOTHY-C/5/6477329.aspx -APTIMUS, Inc. | Sytronics, Inc.; American Access Technologies, Inc.; Digital River, Inc.; The Consus Group; etc. | Alexandria, Virginia.
******
Ralph E. Dittman
http://www.facebook.com/people/Ralph-Dittman/1410905670 - Stem Cell Action Coalition; Texans for Advancement of Medical Research (TAMR), etc.| Houston, Texas.
http://www.facebook.com/people/Ralph-Dittman/1410905670 - Stem Cell Action Coalition; Texans for Advancement of Medical Research (TAMR), etc.| Houston, Texas.******
Jeannie Fontana
http://etopiamedia.net/empnn/pages/cpt-emnn/cpt-emnn497-5551212.html | Los Angeles, California.
http://etopiamedia.net/empnn/pages/cpt-emnn/cpt-emnn497-5551212.html | Los Angeles, California.******
Richard S. Grossberg
http://www.linkedin.com/pub/richard-grossberg/8/b88/b73 - “Franchisor, investor, board member, advisor.” Construction. Founded: US Structures DBA Archadeck. | http://www.corporationwiki.com/Virginia/Richmond/richard-s-grossberg/28381934.aspx | Richmond, Virginia.
http://www.linkedin.com/pub/richard-grossberg/8/b88/b73 - “Franchisor, investor, board member, advisor.” Construction. Founded: US Structures DBA Archadeck. | http://www.corporationwiki.com/Virginia/Richmond/richard-s-grossberg/28381934.aspx | Richmond, Virginia.******
Robert R. Hindle
http://www.stemcellnetwork.ca/index.php?page=board-of-directors&hl=fra | Montreal, Canada.
http://www.stemcellnetwork.ca/index.php?page=board-of-directors&hl=fra | Montreal, Canada.******
Carol Horvitz
http://www.worldstemcellsummit.com/about-summit | http://www.childrenshospital.org/dream/dream_spring06/stem_cell_research.html -”independent investor.” | “Independent Law Practice Professional.” ESCRO Committee Member, etc. Greater Boston Area. | Beverly Farms, Massachusetts.
http://www.worldstemcellsummit.com/about-summit | http://www.childrenshospital.org/dream/dream_spring06/stem_cell_research.html -”independent investor.” | “Independent Law Practice Professional.” ESCRO Committee Member, etc. Greater Boston Area. | Beverly Farms, Massachusetts.******
S. Peter Ludwig
http://www.fr.com/S-Peter-Ludwig/ - ..is a Principal in the New York office of Fish & Richardson. | New York, New York.
http://www.fr.com/S-Peter-Ludwig/ - ..is a Principal in the New York office of Fish & Richardson. | New York, New York.******
Bernard Siegel (above)
——
——
“GPI has recruited the leading stem cell scientists, researchers and physicians in the field of biomedical research to serve on our Scientific Advisory Board.”
—
Genevieve Ames, Ph.D., University of California-Berkeley School of Public Health, Berkeley, California
******
Juan Dominguez Bendala, MSC, PhD., Diabetes Research Institute, Miller School of Medicine, University of Miami, Miami, Florida
******
Elizabeth Blackburn, Ph.D., University of California-San Francisco; Former president, American Society of Cell Biology; Former member of the President’s Council on Bioethics; San Francisco, California
******
William (Bill) Brinkley, PhD., Senior Vice President for Graduate Sciences, Dean of the Graduate School of Biomedical Sciences, Baylor College of Medicine, Houston, Texas
******
Keith H.S. Campbell, BSc, DPhil, Professor of Animal Development, University of Nottingham, United Kingdom
******
Curt I. Civin, MD., Associate Dean of Research, University of Maryland School of Medicine for Stem Cell Research, and Regenerative Medicine, Baltimore, Maryland
******
Gabriela Gebrin Cezar, D.V.M., Ph.D., Assistant Professor, University of Wisconsin-Madison, Madison, Wisconsin
******
Jose B. Cibelli, D.V.M., PhD., Cellular Reprogramming Laboratory, Michigan State University, Lansing, Michigan
http://www.psl.msu.edu/people_faculty.html | http://www.counterbalance.org/bio/cibel-frame.html - Vice President of Research at Advanced Cell Technology Inc., in Worcester, MA., etc.******
W. Dalton Dietrich, Ph.D., Scientific Director, The Miami Project to Cure Paralysis, Miller School of Medicine, University of Miami, Miami, Florida
******
Fred H. Gage, Ph.D., Laboratory of Genetics, Salk Institute for Biological Studies, La Jolla, California
******
John Gearhart, MSc, Ph.D., Director, Institute of Regenerative Medicine, University of Pennsylvania, Philadelphia, Pennsylvania
******
Lawrence Goldstein, Ph.D., Professor of Cellular and Molecular Medicine, University of California, San Diego, San Diego, California
******
Prof. Raphael Gorodetsky, Head, Biotechnology and Radiobiology Labs, Sharett Institute of Oncology; Hadassah – Hebrew University Medical Center, Jerusalem, Israel
http://www.facebook.com/people/Raphael-Gorodetsky/1007882304 | http://www.hadassah.org.il/English/Eng_SubNavBar/TheDoctors/GorodetskyRaphael.htm******
Rudolf Jaenisch, M.D., Member, Whitehead Institute, Professor of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts
******
Timothy J. Kamp, MD, PhD, Professor of Medicine and Physiology, Co-director Stem Cell and Regenerative Medicine Center Cellular and Molecular Arrhythmia Research Program University of Wisconsin Medical School, Madison, Wisconsin
******
Stephen E. Levick, M.D., University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania
******
Alan S. Levine, PhD., Chief Scientific Officer, CORD:USE, Cord Stem Cell Bank, Orlando, Florida
http://publiccordbloodbank.corduse.com/about_leadership.php - Prior to joining CORD:USE, Dr. Levine had a highly successful 25 year career with the National Institutes of Health, where he was most recently the Director of the Blood Disease Program of the National Heart, Lung, and Blood Institute (“NHLBI”). In this capacity, Dr. Levine was responsible for initiating the bone marrow and umbilical cord blood transplant programs at the NHLBI.******
Jeanne F. Loring, Ph.D., Professor of Developmental Neurobiology Director, Center for Regenerative Medicine, The Scripps Research Institute, La Jolla, California
******
Chris Mason MBBS, PhD, FRCS, Regenerative Medicine Bioprocessing Unit Advanced Centre for Biochemical Engineering, University College London, London, United Kingdom
http://www.terrapinn.com/2008/stemcells/speakerList.stm - …is at the forefront of the emerging field of regenerative medicine bioprocessing plus is involved in a number of committees, working groups and initiatives related to both the academic and commercial advancement of stem cells and tissue engineering.******
John W. McDonald, MD., PhD., International Center for Spinal Cord Injury, Kennedy Krieger Institute, Baltimore, Maryland
******
Douglas Melton, Ph.D., Scientific Director, Harvard Stem Cell Institute, Harvard University, Cambridge, Massachusetts
******
Stephen Minger, PhD., Global Director R&D, Cell Technologies, GE Healthcare, London, United Kingdom
******
Roger Pederson, Ph.D., Professor of Regenerative Medicine, University of Cambridge, United Kingdom

******
Mark Noble, PhD., Department of Biomedical Genetics, University of Rochester Medical Center, Rochester, New York
******
Raj Rao, Phd., Department of Clinical and Life Science Engineering, Virginia Commonwealth University, Richmond, Virginia
******
Camillo Ricordi, M.D., Scientific Director, Diabetes Research Institute, Miller School of Medicine, University of Miami, Miami, Florida
******
Prof.Dr.med. Thomas Skutella, Anatomical Institute, University of Tubingen, Tubingin, Germany
******
Evan Snyder, M.D., Ph.D., Program Director, Stem Cells and Regeneration, Burnham Institute for Medical Research, La Jolla, California
******
Clive Svendsen, PhD, Director, Cedars-Sinai Regenerative Medicine Institute, Los Angeles, California
******
Sally Temple, PhD., New York Neural Stem Cell Institute, Albany, New York
******
Alan Trounson, Ph.D., President, California Institute for Regenerative Medicine, San Francisco, California
******
Robert D. Wells, PhD., Director of the Center of Genome Research, Institute of Biosciences and Technology, Texas A&M University, Houston, Texas
******
Ian Willmut, Ph.D., Director, MRC Centre for Regenerative Medicine, Edinburgh, Scotland
http://www.forbes.com/2001/11/27/1127cloning.html - In 1997, Ian Wilmut created Dolly the sheep, the first mammal to be cloned using a process called somatic cell nuclear transfer. On Nov. 25, researchers working at Advanced Cell Technology announced that they used the same process on human cells. They also tried to turn eggs into embryos through parthenogenesis–that is, without any sperm. Their goal was to mine the cloned embryos for stem cells, but none of the embryos divided enough for that to happen, etc. | http://www.nature.com/news/2004/040928/full/news040927-7.html******
Wise Young, PhD. MD., Professor and Chair, W.M. Kleck Center for Collaborative Neuroscience, Rutgers, The State University of New Jersey, New Brunswick, New Jersey
******
Mark A. Zern, M.D., Director, Transplant Research Institute, University of California-Davis, Sacramento, California
******
Fanyi Zeng, MD, PhD, Professor & Associate Director, Shanghai Stem Cell Institute, Institute of Medical Genetics, Shanghai Jiaotong University, Shanghai, China
******
Len Zon, M.D., Director Stem Cell Research Program, Past President, International Society for Stem Cell Research, Children’s Hospital Boston, Harvard University Medical School, Boston, Massachusetts
******
Thomas P. Zwaka, M.D. Ph.D., Center for Cell and Gene Therapy & Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas
——
—
Chris Bell, J.D. – Frmer member U.S. House of Representatives, Houston, Texas

******
Susan L. Crockin, J.D., The Crockin Law & Policy Group, LLC., Newton, Massachusetts
******
James Lawford Davies, Clifford Chance, London, United Kingdom
******
Janet L. Dolgin, PhD, J.D., Jack and Freda Dicker Distinguished Professor of Health Care Law, Hofstra University School of Law, Hempstead, New York
******
Mark S. Ellinger, PhD., J.D., Principal, Fish & Richardson, P.C., Minneapolis, Minnesota
http://www.fr.com/mark-s-ellinger/ - His practice emphasizes patent prosecution, opinions, due diligence investigations, licensing and counseling in the medical biotechnology, agricultural biotechnology, diagnostic, pharmaceutical, and medical science fields. …”Dr.” Ellinger’s projects have involved subject matter such as genomics, proteomics, gene therapy, xenotransplantation, transgenic animals, transgenic plants, metabolic engineering, immunoassays, nucleic acid-based assays, antisense technology, nucleic acid analogues, microarrays, vaccines, stem cells, medical devices, food science, and potential treatments for diseases such as cardiovascular disease, cancer, allergy, arthritis, diabetes, and Alzheimer’s Disease. …His litigation experience includes immunodiagnostics, cardiac assays, microsatellite DNA assays, plant genetics, and transgenic animals. …His licensing experience includes university/industry collaborations, patent outlicensing and inlicensing programs, and joint ventures.******
Richard Falk, Ph.D., Milbank Professor of International Law Emeritus, Princeton University
http://truthjihadradio.blogspot.com/2010/10/princeton-prof-richard-falk-un-human.html | http://mycatbirdseat.com/2011/02/richard-falk-how-honest-is-the-honest-broker/******
Timo Faltus, Dipl. Jur., Dipl. Biol., University of Leipzig, Leipzig, German
******
Louis M. Guenin, J.D., Lecturer on Ethics in Science, Department of Microbiology and Molecular Genetics, Harvard Medical School, Boston, Massachusetts
******
James E. Grossberg, J.D., Levine Sullivan Koch & Schulz, LLP., Washington, D.C.
******
Rosario M. Isasi, JD, MPH, Academic Secretary, International Stem Cell Forum Ethics Working Party; Centre de recherche en droit public (CRDP), Faculty of Law, University de Montreal, Montreal, Canada

******
Alan L. Jakimo, M.B.A., JD., Partner, Sidley Austin, LLP, New York, New York
******
Nihal Jayawickrama, Ph.D., formerly Sallows Professor of Human Rights at the University of Saskatchewan, London, United Kingdom
******
Bruce W. Jenett, J.D., Co-Chair, Global Life Sciences, DLA Piper, Palo Alto, California
******
Prof. Russell Korobkin, UCLA School of Law, Los Angeles, California
******
Ana Lita, PhD., Director, IHEU-Appignani Center for Bioethics at the United Nations, New York, New York
******
S. Peter Ludwig, J.D., Partner, Darby & Darby, New York, New York (see above)
******
David C. Magnus, PhD., Stanford Center for Biomedical Ethics, Stanford University, Palo Alto, California
******
Prof. Fabio Marazzi, Senior Managing Partner, Emmeplus Spa, Milan, Italy
******
Jonathan D. Moreno, PhD., Professor of Medical Ethics, Center for Bioethics, University of Pennsylvania, Philadelphia, Pennsylvania
******
John A. Robertson, J.D., Vinson & Elkins Chair in Law, University of Texas Law School, Austin, Texas
******
Karen Rothenberg, J.D., M.P.A., Chair, Maryland Stem Cell Research Commission, University of Maryland School of Law, Baltimore, Maryland
http://abovethelaw.com/2010/02/is-a-maryland-law-school-dean-worth-800000/ | http://www.law.columbia.edu/faculty/visiting?main.ctrl=contactmgr.detail&main.view=profiles.inline_detail&top.robots=all&global.id=161310&top.title=Karen+Rothenberg******
Douglas A. Sipp, Riken Center for Developmental Biology, Kobe, Japan
******
Christopher Weeramantry, World Court Judge (retired) – Sri Lanka Emeritus Professor of Law at Monash University
******
Laurie Zoloth, PhD, Director, Bioethics, Center for Genetics Medicine, Northwestern University, Evanston, Illinois
——
—
Grant Albrecht – Patient Advocate and President, Communication Unlimited, Los Angeles, California
******
Sabrina Cohen – Founder and Executive Director, Sabrina Cohen Foundation for Stem Cell Research, Miami Beach, Florida
******
Brooke Ellison – Stony Brook, New York
******
Danny Heumann – Ann Arbor, Michigan
******
Linda Powers – Bethesda, Maryland
******
Don C. Reed – Americans for Cures Foundation, Fremont, California
******
Ronald G. Stone – Miami, Florida
http://www.worksitemarketingtraining.com/ronaldstone.htm - President, The Comprehensive Companies.******
Andrew Tobias – New York, New York
******



